Thompson and coworkers also showed that CHRM3 activation did not alter cell proliferation or migration, although it significantly increased cell invasion through complex extracellular matrices mediated by enhanced activity of matrix metalloproteinase-9 (MMP-9) in GBM cells. The gene discussed is CHRM3; the disease is glioblastoma.